This review article provides guidance for advanced practitioners on adequately caring for patients receiving CAR T-cell therapy and the recognition, grading, and appropriate management of treatment-related toxicities, including cytokine release syndrome and associated cardiovascular adverse events such as arrhythmias, cardiomyopathy, and heart block.
Frontiers in Oncology